NORTHERN TRUST CORP - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 2 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$17,000
-22.7%
55,8930.0%0.00%
Q4 2019$22,000
+22.2%
55,8930.0%0.00%
Q3 2019$18,000
+20.0%
55,8930.0%0.00%
Q2 2019$15,000
-76.2%
55,893
-4.4%
0.00%
Q1 2019$63,000
-35.1%
58,493
+4.0%
0.00%
Q4 2018$97,000
-71.2%
56,220
-3.1%
0.00%
Q3 2018$337,000
+33.2%
58,025
-2.0%
0.00%
Q2 2018$253,000
-85.4%
59,214
-79.9%
0.00%
Q1 2018$1,729,000
+31.1%
294,617
+3.2%
0.00%
Q4 2017$1,319,000
-16.9%
285,401
-1.3%
0.00%
Q3 2017$1,587,000
-7.3%
289,221
-2.7%
0.00%
Q2 2017$1,712,000
+637.9%
297,152
+640.6%
0.00%
Q1 2017$232,000
+88.6%
40,122
+71.6%
0.00%
Q4 2016$123,000
+179.5%
23,376
+6.4%
0.00%
Q3 2016$44,000
-2.2%
21,9680.0%0.00%
Q2 2016$45,000
-4.3%
21,9680.0%0.00%
Q1 2016$47,000
-25.4%
21,9680.0%0.00%
Q4 2015$63,000
-36.4%
21,968
-1.3%
0.00%
Q3 2015$99,000
+28.6%
22,259
+105.2%
0.00%
Q1 2015$77,000
+1.3%
10,8460.0%0.00%
Q4 2014$76,000
+16.9%
10,846
+2.8%
0.00%
Q3 2014$65,000
-88.7%
10,555
-83.2%
0.00%
Q2 2014$574,000
-18.3%
62,993
-27.1%
0.00%
Q1 2014$703,000
+46.2%
86,375
+16.0%
0.00%
Q4 2013$481,00074,4890.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders